跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 306 条关于
“IgG2”
全部
306
临床试验
206
药物
54
机构
0
资讯
46
2个月前
First SARS-CoV-2 Exposure Shapes IgG Subclass Switching and Breakthrough Infection Risk After mRNA Vaccination
上个月
Kiniksa Raises ARCALYST Guidance to $995M as KPL-387 Advances into Pivotal Phase 3 for Recurrent Pericarditis
去年
Novartis Acquires Tourmaline Bio for $1.4 Billion to Advance Anti-Inflammatory Cardiovascular Therapy
7年前
Glembatumumab Vedotin Fails to Meet Efficacy Endpoint in Recurrent Osteosarcoma Phase II Trial
2年前
EMA Validates Marketing Applications for HLX14 Denosumab Biosimilar in Osteoporosis Treatment
11个月前
BioInvent to Present Phase 1 Data for BI-1910 TNFR2 Agonist at SITC Despite Pausing Development
去年
Amgen Settles Denosumab Biosimilar Patent Dispute with Accord BioPharma
9个月前
Acumen Pharmaceuticals Demonstrates 68-Fold Increase in Brain Delivery for Alzheimer's Antibody Using Novel Transferrin Receptor Technology
去年
Kiniksa Pharmaceuticals Advances KPL-387 Phase 2/3 Trial for Recurrent Pericarditis
去年
2D4 Monoclonal Antibody Shows Promise in Treating Systemic Lupus Erythematosus by Targeting CD132
第 1 页,共 5 页
上一页
下一页